PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland
Abstract
Authors
A. Gadaj A. Kalinowska D. Hawrylecka J. Holojda A. Krawcewicz W. Spychalowicz M. Russel-Szymczyk M. Szkultecka-debek